drugset / Trial / NCT00667797
Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects
RandomizedParallel-groupOpen-labelHealth-services research
Summary
An analysis of the costs and outcomes associated with hospitalization and treatment of Levalbuterol versus Racemic Albuterol in subjects with Asthma and COPD.
Timeline
- Start
- 2003-03
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levalbuterol | Other / unclassified | 1.25 mg | Inhaled |
| Comparator | Salbutamol | Unknown | 2.5 mg | Inhaled |